• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

考虑到疫苗库存数量和每日接种能力的限制,疫苗接种对流感爆发的缓解作用。

Mitigating effects of vaccination on influenza outbreaks given constraints in stockpile size and daily administration capacity.

机构信息

Mathematical, Computational, and Modeling Sciences Center, Arizona State University, Tempe, AZ, USA.

出版信息

BMC Infect Dis. 2011 Aug 1;11:207. doi: 10.1186/1471-2334-11-207.

DOI:10.1186/1471-2334-11-207
PMID:21806800
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3162903/
Abstract

BACKGROUND

Influenza viruses are a major cause of morbidity and mortality worldwide. Vaccination remains a powerful tool for preventing or mitigating influenza outbreaks. Yet, vaccine supplies and daily administration capacities are limited, even in developed countries. Understanding how such constraints can alter the mitigating effects of vaccination is a crucial part of influenza preparedness plans. Mathematical models provide tools for government and medical officials to assess the impact of different vaccination strategies and plan accordingly. However, many existing models of vaccination employ several questionable assumptions, including a rate of vaccination proportional to the population at each point in time.

METHODS

We present a SIR-like model that explicitly takes into account vaccine supply and the number of vaccines administered per day and places data-informed limits on these parameters. We refer to this as the non-proportional model of vaccination and compare it to the proportional scheme typically found in the literature.

RESULTS

The proportional and non-proportional models behave similarly for a few different vaccination scenarios. However, there are parameter regimes involving the vaccination campaign duration and daily supply limit for which the non-proportional model predicts smaller epidemics that peak later, but may last longer, than those of the proportional model. We also use the non-proportional model to predict the mitigating effects of variably timed vaccination campaigns for different levels of vaccination coverage, using specific constraints on daily administration capacity.

CONCLUSIONS

The non-proportional model of vaccination is a theoretical improvement that provides more accurate predictions of the mitigating effects of vaccination on influenza outbreaks than the proportional model. In addition, parameters such as vaccine supply and daily administration limit can be easily adjusted to simulate conditions in developed and developing nations with a wide variety of financial and medical resources. Finally, the model can be used by government and medical officials to create customized pandemic preparedness plans based on the supply and administration constraints of specific communities.

摘要

背景

流感病毒是全球发病率和死亡率的主要原因。疫苗接种仍然是预防或减轻流感爆发的有力工具。然而,即使在发达国家,疫苗供应和日常管理能力也有限。了解这些限制如何改变疫苗接种的缓解效果是流感防范计划的重要组成部分。数学模型为政府和医疗官员提供了评估不同疫苗接种策略影响并相应计划的工具。然而,许多现有的疫苗接种模型采用了几个有问题的假设,包括疫苗接种率与每个时间点的人口成正比。

方法

我们提出了一个类似于 SIR 的模型,该模型明确考虑了疫苗供应和每天接种的疫苗数量,并对这些参数进行了数据驱动的限制。我们将其称为非比例疫苗接种模型,并将其与文献中通常发现的比例方案进行比较。

结果

对于几种不同的疫苗接种情况,比例和非比例模型的行为相似。然而,在涉及疫苗接种活动持续时间和每日供应限制的参数范围内,非比例模型预测的疫情较小,峰值较晚,但可能持续时间更长,而比例模型则预测的疫情较大,峰值较早。我们还使用非比例模型来预测不同疫苗接种覆盖率水平下不同时间安排的疫苗接种活动的缓解效果,同时使用每日管理能力的具体限制。

结论

非比例疫苗接种模型是一种理论上的改进,它比比例模型更准确地预测了疫苗接种对流感爆发的缓解效果。此外,疫苗供应和每日管理限制等参数可以轻松调整,以模拟具有各种财务和医疗资源的发达国家和发展中国家的情况。最后,该模型可由政府和医疗官员使用,根据特定社区的供应和管理限制制定定制的大流行性流感防范计划。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3fb/3162903/c4220249d6bf/1471-2334-11-207-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3fb/3162903/10a980ae86c4/1471-2334-11-207-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3fb/3162903/8eeb54dd2c5f/1471-2334-11-207-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3fb/3162903/e3726a7e7c56/1471-2334-11-207-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3fb/3162903/c4220249d6bf/1471-2334-11-207-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3fb/3162903/10a980ae86c4/1471-2334-11-207-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3fb/3162903/8eeb54dd2c5f/1471-2334-11-207-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3fb/3162903/e3726a7e7c56/1471-2334-11-207-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3fb/3162903/c4220249d6bf/1471-2334-11-207-4.jpg

相似文献

1
Mitigating effects of vaccination on influenza outbreaks given constraints in stockpile size and daily administration capacity.考虑到疫苗库存数量和每日接种能力的限制,疫苗接种对流感爆发的缓解作用。
BMC Infect Dis. 2011 Aug 1;11:207. doi: 10.1186/1471-2334-11-207.
2
Modeling pandemic preparedness scenarios: health economic implications of enhanced pandemic vaccine supply.模拟大流行防范情景:增加大流行疫苗供应对卫生经济的影响。
Virus Res. 2004 Jul;103(1-2):9-15. doi: 10.1016/j.virusres.2004.02.006.
3
Pandemic influenza vaccines: meeting the supply, distribution and deployment challenges.大流行性流感疫苗:应对供应、分发和部署挑战
Influenza Other Respir Viruses. 2009 Jul;3(4):165-70. doi: 10.1111/j.1750-2659.2009.00085.x.
4
Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010.改进流感疫苗病毒选择:世卫组织于 2010 年 6 月 14 日至 16 日在瑞士日内瓦世卫组织总部举行的一次世卫组织非正式磋商的报告。
Influenza Other Respir Viruses. 2012 Mar;6(2):142-52, e1-5. doi: 10.1111/j.1750-2659.2011.00277.x. Epub 2011 Aug 8.
5
Optimizing the dose of pre-pandemic influenza vaccines to reduce the infection attack rate.优化大流行前流感疫苗的剂量以降低感染攻击率。
PLoS Med. 2007 Jun;4(6):e218. doi: 10.1371/journal.pmed.0040218.
6
Are we prepared to help low-resource communities cope with a severe influenza pandemic?我们是否准备好帮助资源匮乏的社区应对严重流感大流行?
Influenza Other Respir Viruses. 2013 Nov;7(6):909-13. doi: 10.1111/irv.12040. Epub 2012 Nov 12.
7
Influenza vaccine supply: building long-term sustainability.流感疫苗供应:建立长期可持续性。
Vaccine. 2008 Sep 12;26 Suppl 4:D23-6. doi: 10.1016/j.vaccine.2008.07.067.
8
Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.确定流感疫苗接种在欧盟25个国家内对健康和经济的影响。
Vaccine. 2006 Nov 17;24(47-48):6812-22. doi: 10.1016/j.vaccine.2006.07.042. Epub 2006 Aug 4.
9
Influenza vaccination in preventing outbreaks in schools: A long-term ecological overview.流感疫苗接种预防学校暴发:一项长期的生态学综述。
Vaccine. 2017 Dec 18;35(51):7133-7138. doi: 10.1016/j.vaccine.2017.10.096. Epub 2017 Nov 8.
10
Challenges and changes: immunization program managers share perspectives in a 2012 national survey about the US immunization system since the H1N1 pandemic response.挑战与变革:免疫规划管理者分享 2012 年美国免疫体系国家调查的观点——自 H1N1 大流行应对以来。
Hum Vaccin Immunother. 2014;10(10):2915-21. doi: 10.4161/21645515.2014.972798.

引用本文的文献

1
A systematic literature review on public health and healthcare resources for pandemic preparedness planning.系统文献回顾:大流行准备规划中的公共卫生和医疗资源
BMC Public Health. 2024 Nov 11;24(1):3114. doi: 10.1186/s12889-024-20629-z.
2
Building resource constraints and feasibility considerations in mathematical models for infectious disease: A systematic literature review.构建传染病数学模型中的资源约束和可行性考虑因素:系统文献综述。
Epidemics. 2021 Jun;35:100450. doi: 10.1016/j.epidem.2021.100450. Epub 2021 Mar 13.
3
Controlling infectious disease outbreaks: A deterministic allocation-scheduling model with multiple discrete resources.

本文引用的文献

1
A perspective on the 2009 A/H1N1 influenza pandemic in Mexico.对墨西哥 2009 年 A/H1N1 流感大流行的看法。
Math Biosci Eng. 2011 Jan;8(1):223-38. doi: 10.3934/mbe.2011.8.223.
2
Modeling control strategies for concurrent epidemics of seasonal and pandemic H1N1 influenza.季节性和大流行性 H1N1 流感并发疫情的控制策略建模。
Math Biosci Eng. 2011 Jan;8(1):141-70. doi: 10.3934/mbe.2011.8.141.
3
Evaluation of vaccination strategies during pandemic outbreaks.大流行疫情期间的疫苗接种策略评估。
控制传染病爆发:一种具有多种离散资源的确定性分配调度模型。
J Syst Sci Syst Eng. 2017;26(2):219-239. doi: 10.1007/s11518-016-5327-z. Epub 2017 Jan 24.
4
Biosafety risk assessment for production of candidate vaccine viruses to protect humans from zoonotic highly pathogenic avian influenza viruses.生产候选疫苗病毒以保护人类免受人畜共患高致病性禽流感病毒的生物安全风险评估。
Influenza Other Respir Viruses. 2020 Mar;14(2):215-225. doi: 10.1111/irv.12698. Epub 2019 Oct 28.
5
Efficient Vaccine Distribution Based on a Hybrid Compartmental Model.基于混合分区模型的高效疫苗分配
PLoS One. 2016 May 27;11(5):e0155416. doi: 10.1371/journal.pone.0155416. eCollection 2016.
Math Biosci Eng. 2011 Jan;8(1):113-22. doi: 10.3934/mbe.2011.8.113.
4
Multiple outbreaks for the same pandemic: Local transportation and social distancing explain the different "waves" of A-H1N1pdm cases observed in México during 2009.多次爆发同一大流行:本地交通和社交距离解释了 2009 年在墨西哥观察到的 A-H1N1pdm 病例的不同“波”。
Math Biosci Eng. 2011 Jan;8(1):21-48. doi: 10.3934/mbe.2011.8.21.
5
Influenza pandemic waves under various mitigation strategies with 2009 H1N1 as a case study.以 2009 年 H1N1 为案例研究的不同缓解策略下的流感大流行波。
PLoS One. 2010 Dec 20;5(12):e14307. doi: 10.1371/journal.pone.0014307.
6
A tool for the economic analysis of mass prophylaxis operations with an application to H1N1 influenza vaccination clinics.一种用于大规模预防接种行动经济分析的工具及其在 H1N1 流感疫苗接种门诊中的应用。
J Public Health Manag Pract. 2011 Jan-Feb;17(1):E22-8. doi: 10.1097/PHH.0b013e3181f87952.
7
Lessons from pandemic influenza A(H1N1): the research-based vaccine industry's perspective.大流行性流感 A(H1N1)的教训:基于研究的疫苗产业的观点。
Vaccine. 2011 Feb 1;29(6):1135-8. doi: 10.1016/j.vaccine.2010.11.042. Epub 2010 Nov 27.
8
Incidence of hospital admissions and severe outcomes during the first and second waves of pandemic (H1N1) 2009.大流行(H1N1)2009 年第一波和第二波期间的住院和严重后果发生率。
CMAJ. 2010 Dec 14;182(18):1981-7. doi: 10.1503/cmaj.100746. Epub 2010 Nov 8.
9
Mass vaccination for the 2009 H1N1 pandemic: approaches, challenges, and recommendations.2009年甲型H1N1流感大流行的大规模疫苗接种:方法、挑战与建议。
Biosecur Bioterror. 2010 Dec;8(4):321-30. doi: 10.1089/bsp.2010.0043. Epub 2010 Nov 2.
10
Vaccination deep into a pandemic wave potential mechanisms for a "third wave" and the impact of vaccination.大流行浪潮中的疫苗接种:“第三波”的潜在机制和疫苗接种的影响。
Am J Prev Med. 2010 Nov;39(5):e21-9. doi: 10.1016/j.amepre.2010.07.014.